Key Takeaways BHC posted Q2 EPS of $0.90, missing estimates, while revenues rose 5% to $2.53B, beating forecasts.Salix revenues grew 12% to $627M, driven by higher demand for Xifaxan, Trulance, and Relistor.BHC is set to acquire DRRX for $63M, along with milestone payments. Shares of Bausch Health Companies Inc. ((BHC) declined 6.3% after the company reported mixed results for the second quarter of 2025.Adjusted earnings per share of 90 cents missed the Zacks Consensus Estimate of 97 cents. The earnings wer ...